USPTO serial 79255282
ALYVANT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 30, 2020
- Examiner
- BURDECKI, ANNA C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALYVANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Allison Strickland Ricketts
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for providing, analyzing and generating reports; computer software for data processing; software and computer programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; software and computer programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analyzing data in the fields of public health, healthcare, namely pharmaceutical commercialization, biomedical research and software for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest related to disease awareness or pharmaceutical products; computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information | ACTIVE | — |
| 035 | Advertising services related to pharmaceutical products; business management; business administration; business research and information services; market research and provision of information regarding market research; data processing services; analysis of business data; business data and statistical analysis, documentation being compilation of statistics and professional business consultancy services regarding statistics for biomedical research, namely, related to pharmaceutical commercialization, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business data analysis and statistical analysis of healthcare data, biomedical research and clinical trial data for business purposes to include pharmaceutical commercialization; systematization and compilation of data in computer databases; business research, market testing being market research and statistical analysis services for business purposes in the fields of public health, healthcare and biomedicine, namely, pharmaceutical commercialization and products, and for clinical trials; business advisory services, consultancy and information; advertising, marketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticals, public health and healthcare; providing an on-line database providing business intelligence in the fields of pharmaceuticals, public health and healthcare | ACTIVE | — |
| 041 | Educational services, namely arranging, conducting and organizing classes, seminars, conferences, symposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals, and distribution of training materials in connection therewith | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of software for managing healthcare data; analysis of technical data by computers, being technical medical research in the field of healthcare, prescription and related data being carried out using computers; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software for allowing users to connect to databases containing pharmaceutical and medical information; providing temporary use of online non-downloadable computer software for management of medical practices and research in connection with or related to pharmaceutical commercialization; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information | ACTIVE | — |
| 044 | Providing health and medical information to potential customers of pharmaceutical products; providing internet-based healthcare information in support of potential commercialization of pharmaceutical products for the treatment of diseases, disorders or conditions; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; medical services, namely, providing medical services and consultation related to pharmaceutical products or disease awareness over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; pharmaceutical advice; medical and pharmaceutical consultation related to pharmaceutical products or disease awareness; medical assistance in the nature of the provision of medical information, namely, information related to pharmaceutical products or disease awareness for medical professionals and potential patients from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALYVANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 8, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 20, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 20, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 30, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 30, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 25, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 25, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 11, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 5, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 2, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 9, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 9, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 9, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 17, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 2, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 2, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 28, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |